Revvity

Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries,[1] especially in relation to approaches making use of new cell therapy or gene therapy developments.[2] Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines.[3]

Revvity, Inc.

Formerly	PerkinElmer, Inc.
Type	Public company
Traded as	NYSE: RVTY S&P 500 component
Industry	Biotechnology
Founded	May 9, 2023 (2023-05-09) in Waltham, Massachusetts, U.S.
Headquarters	Waltham, Massachusetts , U.S.
Key people	Prahlad Singh (President and CEO)
Revenue	US$3 billion (2022)
Number of employees	11,000 worldwide (2023)
Subsidiaries	BioLegend EUROIMMUN Tulip Diagnostics ViaCord
Website	revvity.com

In 2022, a split of PerkinElmer resulted in one part, comprising its applied, food and enterprise services businesses, being sold to the private equity firm New Mountain Capital for $2.45 billion and thus no longer being public but keeping the PerkinElmer name. The other part, comprised of the life sciences and diagnostics businesses, remained public but required a new name, which in 2023 was announced as Revvity, Inc.[3] From the perspective of Revvity, the goal of creating a separate company was that its businesses might show greater profit margins and more in the way of growth potential.[1] An associated goal was to have more financial flexibility moving forward.[3] On May 16, 2023, the PerkinElmer stock symbol PKI was replaced by the new symbol RVTY.[4][3]

The name 'Revvity' itself was formed from a combination of the words "revolution" (abrupt change, in English) and "vita" (life, in Latin).[1] It was the larger of the two splitees: of around 17,000 employees of the public PerkinElmer, about 11,000 of them were assigned to it, while some 6,000 went to the newly private PerkinElmer.[4] Initial annual revenues for Revvity were estimated at about $3 billion.[1] Singh and some other senior executives came to Revvity from PerkinElmer, while others were new hires.[4] Headquarters for Revvity were kept in the same town as the old PerkinElmer, that being Waltham, Massachusetts.[1]

Compared with its PerkinElmer past, Revvity was deemphasing medical devices in favor of an approach based on reagents and electronic commerce.[2]